Burjeel Holdings, one of the leading private healthcare service providers in the Middle East, has announced a 15.6% increase in annual revenue and 52.4% increase in net profit in 2023. The annual revenue increase amounts to AED 4.5 billion, while the net profit stands at 540 million.

With a mission of delivering medical care through state-of-the-art technology and exemplary medical experts, Burjeel Holdings aims to stay committed to accessible healthcare solutions in the Middle East.

According to the World Economic Forum, Burjeel Holdings employs over 10,000 professionals and treats more than 4.3 million patients in a year. Founded in 2007 by Dr. Shamsheer Vayalil, who is grateful for the support from the UAE government, Burjeel Holdings has ambitious expansion plans. A confirmation of its first interim dividend payment was made in August 2023, with the intention of returning about AED 95 million to shareholders. In 2022, the group announced a Memorandum of Understanding with the Kingdom of Saudi Arabia Ministry of Investment and its intention of seeking opportunities to invest up to USD $1.0 billion in KSA by 2030.

PhysioTherabia rehabilitation network in Saudi Arabia launched in October last year is rapidly growing. The centers located in Riyadh will be the first of 60 advanced physiotherapy, rehabilitation, and wellness units to be established across the UAE. This month, Burjeel opened eight PhysioTherabia centers in Riyadh, Yanbu, Jeddah, Dammam, and Al Khobar, in line with Saudi Arabia’s Vision 2030. Just last month, Burjeel’s board of directors approved the launch of two specialized day surgery centers in Riyadh as part of the Group’s regional expansion in KSA. The centers will tap into the increasing demand for world-class medical services and offer premium care to patients from around the world. The centers would constitute key specialities in Oncology, Advanced Gynecology, Orthopedics and Neurology, and are expected to each generate an annual revenue of around SAR 150 to 200 million, once they become operational.

Dr. Shamsheer Vayalil, Founder and Non-Executive Chairman of Burjeel Holdings, has said that Burjeel’s recent investment in state-of-the-art Da Vinci robotic surgical system and Novalis accreditation for its radiation oncology practice are just two examples of their progress in innovation.

John Sunil, Chief Executive Officer of Burjeel Holdings, has supported the view. He has said that their robust top-line and bottom-line growth, besides impressive operational performance, stand witness to the success of their strategy.